218 related articles for article (PubMed ID: 23005599)
1. Case reports of primary pulmonary adenocarcinoma with pleural spread: so-called pseudomesotheliomatous adenocarcinoma.
Saito R; Kasajima A; Taniuchi S; Fujishima F; Ishida K; Nakamura Y; Yamanda S; Takahashi T; Hitomi H; Murakami K; Watanabe M; Sasano H
Pathol Int; 2012 Oct; 62(10):709-15. PubMed ID: 23005599
[TBL] [Abstract][Full Text] [Related]
2. Coalescent pleural malignant mesothelioma and adenocarcinoma of the lung, involving only minor asbestos exposure.
Tsuzuki T; Ninomiya H; Natori Y; Ishikawa Y
Pathol Int; 2008 Jul; 58(7):451-5. PubMed ID: 18577116
[TBL] [Abstract][Full Text] [Related]
3. Synchronous occurrence of pulmonary adenocarcinoma and pleural diffuse malignant mesothelioma.
Imenpour H; Ivaldi GP; Brianti A; Pastorino G; Biggi S; Auriati L; Simonassi C
Pathologica; 2013 Dec; 105(6):353-6. PubMed ID: 24730341
[TBL] [Abstract][Full Text] [Related]
4. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
5. [Clinical comparison of diffuse malignant mesothelioma of the pleura and pseudomesotheliomatous carcinoma of the lung for each case].
Yuasa H; Tomoyasu M
Kyobu Geka; 1999 Sep; 52(10):836-9. PubMed ID: 10478545
[TBL] [Abstract][Full Text] [Related]
6. [Pseudomesotheliomatous carcinoma of the lung].
Maeda R; Isowa N; Kawasaki Y; Tokuyasu H; Itakura A; Miura H; Onuma H
Kyobu Geka; 2007 Jul; 60(7):555-8. PubMed ID: 17642217
[TBL] [Abstract][Full Text] [Related]
7. The forensic significance of pseudomesotheliomatous adenocarcinoma of the lung.
Kennedy JM
Forensic Sci Med Pathol; 2019 Sep; 15(3):458-462. PubMed ID: 30927189
[TBL] [Abstract][Full Text] [Related]
8. 'Pseudomesotheliomatous' carcinomas of the pleura: a 10-year analysis of cases from the Environmental Lung Disease Research Group, Cardiff.
Attanoos RL; Gibbs AR
Histopathology; 2003 Nov; 43(5):444-52. PubMed ID: 14636270
[TBL] [Abstract][Full Text] [Related]
9. Novel marker D2-40, combined with calretinin, CEA, and TTF-1: an optimal set of immunodiagnostic markers for pleural mesothelioma.
Mimura T; Ito A; Sakuma T; Ohbayashi C; Yoshimura M; Tsubota N; Okita Y; Okada M
Cancer; 2007 Mar; 109(5):933-8. PubMed ID: 17279584
[TBL] [Abstract][Full Text] [Related]
10. Pseudomesotheliomatous adenocarcinoma of the lung with rhabdoid features.
Attems JH; Lintner F
Pathol Res Pract; 2001; 197(12):841-6. PubMed ID: 11795833
[TBL] [Abstract][Full Text] [Related]
11. Pleural mesothelioma in situ and its adenocarcinoma simulator.
Bono F
Int J Surg Pathol; 2010 Dec; 18(6):519-20. PubMed ID: 21081535
[No Abstract] [Full Text] [Related]
12. Is D2-40 a useful marker for distinguishing malignant mesothelioma from pulmonary adenocarcinoma and benign mesothelial proliferations?
Deniz H; Kibar Y; Güldür ME; Bakir K
Pathol Res Pract; 2009; 205(11):749-52. PubMed ID: 19573998
[TBL] [Abstract][Full Text] [Related]
13. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological analysis of lung cancer resembling malignant pleural mesothelioma.
Kobashi Y; Matsushima T; Irei T
Respirology; 2005 Nov; 10(5):660-5. PubMed ID: 16268922
[TBL] [Abstract][Full Text] [Related]
15. Glycosaminoglycans in malignant diffuse mesothelioma.
Kawai T; Suzuki M; Shinmei M; Maenaka Y; Kageyama K
Cancer; 1985 Aug; 56(3):567-74. PubMed ID: 4005813
[TBL] [Abstract][Full Text] [Related]
16. [Pleuropulmonary tumors. Presentation of 2 cases with peculiar clinicopathologic traits].
Esquius Soriguera J; Alejo Sánchez M; Padilla Navas I; Rodríguez Casquero C; León González C
Rev Clin Esp; 1989 Oct; 185(6):303-5. PubMed ID: 2623239
[TBL] [Abstract][Full Text] [Related]
17. Primary thymic epithelial tumours of the pleura mimicking malignant mesothelioma.
Attanoos RL; Galateau-Salle F; Gibbs AR; Muller S; Ghandour F; Dojcinov SD
Histopathology; 2002 Jul; 41(1):42-9. PubMed ID: 12121236
[TBL] [Abstract][Full Text] [Related]
18. Well-differentiated papillary mesothelioma with invasion to the chest wall.
Torii I; Hashimoto M; Terada T; Kondo N; Fushimi H; Shimazu K; Takeda S; Takuwa T; Okumura Y; Sato A; Yamamoto T; Fukuoka K; Tanaka F; Nishigami T; Nakano T; Hasegawa S; Tsujimura T
Lung Cancer; 2010 Feb; 67(2):244-7. PubMed ID: 19880210
[TBL] [Abstract][Full Text] [Related]
19. Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma.
Pan CC; Chen PC; Chou TY; Chiang H
Hum Pathol; 2003 Nov; 34(11):1155-62. PubMed ID: 14652817
[TBL] [Abstract][Full Text] [Related]
20. [A case of triple malignancies (gastric cancer, lung cancer and malignant pleural mesothelioma) after asbestos exposure].
Kishimoto T
Nihon Kokyuki Gakkai Zasshi; 2003 Apr; 41(4):304-9. PubMed ID: 12795187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]